2018-2023 Global Pneumoconiosis Market Report (Status and Outlook)

August 2018 | 118 pages | ID: 2D3E5F4E72CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pneumoconiosis market for 2018-2023.

Pneumoconiosis is an occupational lung disease and a restrictive lung disease caused by the inhalation of dust, often in mines and from agriculture.
In 2013 pneumoconiosis resulted in 260,000 deaths up from 251,000 deaths in 1990. Of these deaths 46,000 were due to silicosis, 24,000 due to asbestosis and 25,000 due to coal workers pneumoconiosis.
Over the next five years, LPI(LP Information) projects that Pneumoconiosis will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Pneumoconiosis market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Asbestosis
• Berylliosis
• Coal Workers Pneumoconiosis
• Silicosis

Segmentation by application:

• Hospitals
• Clinics

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Novartis
• Abbott
• Eli Lilly
• Sunpharma
• Sanofi
• Novo Nordisk
• AstraZeneca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Pneumoconiosis market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Pneumoconiosis market by identifying its various subsegments.
• Focuses on the key global Pneumoconiosis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Pneumoconiosis with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Pneumoconiosis submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pneumoconiosis Market Size 2013-2023
  2.1.2 Pneumoconiosis Market Size CAGR by Region
2.2 Pneumoconiosis Segment by Type
  2.2.1 Asbestosis
  2.2.2 Berylliosis
  2.2.3 Byssinosis
  2.2.4 Coal Workers Pneumoconiosis
  2.2.5 Silicosis
2.3 Pneumoconiosis Market Size by Type
  2.3.1 Global Pneumoconiosis Market Size Market Share by Type (2013-2018)
  2.3.2 Global Pneumoconiosis Market Size Growth Rate by Type (2013-2018)
2.4 Pneumoconiosis Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
2.5 Pneumoconiosis Market Size by Application
  2.5.1 Global Pneumoconiosis Market Size Market Share by Application (2013-2018)
  2.5.2 Global Pneumoconiosis Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PNEUMOCONIOSIS BY PLAYERS

3.1 Global Pneumoconiosis Market Size Market Share by Players
  3.1.1 Global Pneumoconiosis Market Size by Players (2016-2018)
  3.1.2 Global Pneumoconiosis Market Size Market Share by Players (2016-2018)
3.2 Global Pneumoconiosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PNEUMOCONIOSIS BY REGIONS

4.1 Pneumoconiosis Market Size by Regions
4.2 Americas Pneumoconiosis Market Size Growth
4.3 APAC Pneumoconiosis Market Size Growth
4.4 Europe Pneumoconiosis Market Size Growth
4.5 Middle East & Africa Pneumoconiosis Market Size Growth

5 AMERICAS

5.1 Americas Pneumoconiosis Market Size by Countries
5.2 Americas Pneumoconiosis Market Size by Type
5.3 Americas Pneumoconiosis Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Pneumoconiosis Market Size by Countries
6.2 APAC Pneumoconiosis Market Size by Type
6.3 APAC Pneumoconiosis Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Pneumoconiosis by Countries
7.2 Europe Pneumoconiosis Market Size by Type
7.3 Europe Pneumoconiosis Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pneumoconiosis by Countries
8.2 Middle East & Africa Pneumoconiosis Market Size by Type
8.3 Middle East & Africa Pneumoconiosis Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PNEUMOCONIOSIS MARKET FORECAST

10.1 Global Pneumoconiosis Market Size Forecast (2018-2023)
10.2 Global Pneumoconiosis Forecast by Regions
  10.2.1 Global Pneumoconiosis Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Pneumoconiosis Forecast by Type
10.8 Global Pneumoconiosis Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Company Details
  11.1.2 Pneumoconiosis Product Offered
  11.1.3 Novartis Pneumoconiosis Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Novartis News
11.2 Abbott
  11.2.1 Company Details
  11.2.2 Pneumoconiosis Product Offered
  11.2.3 Abbott Pneumoconiosis Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Abbott News
11.3 Eli Lilly
  11.3.1 Company Details
  11.3.2 Pneumoconiosis Product Offered
  11.3.3 Eli Lilly Pneumoconiosis Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Eli Lilly News
11.4 Sunpharma
  11.4.1 Company Details
  11.4.2 Pneumoconiosis Product Offered
  11.4.3 Sunpharma Pneumoconiosis Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Sunpharma News
11.5 Sanofi
  11.5.1 Company Details
  11.5.2 Pneumoconiosis Product Offered
  11.5.3 Sanofi Pneumoconiosis Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Sanofi News
11.6 Novo Nordisk
  11.6.1 Company Details
  11.6.2 Pneumoconiosis Product Offered
  11.6.3 Novo Nordisk Pneumoconiosis Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Novo Nordisk News
11.7 AstraZeneca
  11.7.1 Company Details
  11.7.2 Pneumoconiosis Product Offered
  11.7.3 AstraZeneca Pneumoconiosis Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 AstraZeneca News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Pneumoconiosis
Figure Pneumoconiosis Report Years Considered
Figure Market Research Methodology
Figure Global Pneumoconiosis Market Size Growth Rate 2013-2023 ($ M